Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT03295292Phase 1Unknown
Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze
Corneal Scars and Opacities
PrincipalinvestigatorStart date: 2017-08-01
NCT02568527Not ApplicableCompleted
Biodegradable Synthetic Scaffold as a Substitute for hAM in Limbal Epithelial Cells Transplant in LSCD Patients
Limbal Stem Cell Deficiency
StudydirectorStart date: 2015-10-01

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

LV Prasad Eye Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yonathan Garfias, MD, PhD

Instituto de Oftalmologia Conde de Valenciana

Related
1 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Maryam Momeni, MSc

Department of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Related
1 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Boris E Malyugin, MD PhD Prof

The S. Fyodorov Eye Microsurgery Federal State Institution

Related
1 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Marzieh Ebrahimi, PhD

Royan Institute, Tehran, Iran

Related
1 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Hossein Baharvand, PhD

Royan institute, Tehran, Iran

Related
3 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Alireza Baradaran, MD

Labafi Nejad Eye Research Center, Tehran, Iran

Related
1 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Nadia Zakaria, MBBS, PhD

University Hospital, Antwerp

Related
1 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Marzieh Ebrahimi, PhD

Department of Regenerative Biomedicine at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Related
2 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Carina Koppen, MD, PhD

University Hospital, Antwerp

Related
2 trials

Shared therapeutic areas:

Limbal Stem Cell Deficiency
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03295292Phase 1PrincipalInvestigator

Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze

Corneal Scars and Opacities
Unknown
NCT02568527Not ApplicableStudyDirector

Biodegradable Synthetic Scaffold as a Substitute for hAM in Limbal Epithelial Cells Transplant in LSCD Patients

Limbal Stem Cell Deficiency
Completed

All 2 trials loaded